These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1671886)

  • 1. [The hazards of combining beta receptor blockaders and certain calcium antagonists].
    Lakartidningen; 1991 Jan; 88(3):148. PubMed ID: 1671886
    [No Abstract]   [Full Text] [Related]  

  • 2. Combinations of beta-blockers and calcium channel blockers: a cause of malignant perioperative conduction disturbances?
    Hartwell BL; Mark JB
    Anesth Analg; 1986 Aug; 65(8):905-7. PubMed ID: 2873761
    [No Abstract]   [Full Text] [Related]  

  • 3. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
    Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL
    J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impossible to document adverse effects of calcium antagonists. Effects equal to those of conservative treatment of hypertension].
    Nilsson P
    Lakartidningen; 2000 Aug; 97(35):3710-2. PubMed ID: 11016222
    [No Abstract]   [Full Text] [Related]  

  • 5. [Side effects of cardiac glycosides, calcium antagonists and beta blockers in the secondary data of the legal health insurance].
    Krappweis J; von Ferber L; Köster I
    Verh Dtsch Ges Inn Med; 1989; 95():693-9. PubMed ID: 2574925
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium blockers and coronary risk factors: from the stand point of primary care].
    Baena Díez JM; Comet Jaumet D; Sancho Perpiñán A; Oller Colom M
    Med Clin (Barc); 1997 Nov; 109(18):726-7. PubMed ID: 9499151
    [No Abstract]   [Full Text] [Related]  

  • 8. [The choked heart].
    Furrer F; Giambarba C
    Praxis (Bern 1994); 2012 Jul; 101(14):919-22. PubMed ID: 22763935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating coexisting cardiovascular and pulmonary disease with calcium antagonists.
    Berman BA; Ross RN
    Ann Allergy; 1986 Mar; 56(3):195-200. PubMed ID: 2420238
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination of slow-release diltiazem and a beta-blocker in arterial hypertension. 2 cases of cardiogenic shock with severe bradycardia].
    Lamaison D; Vacher D; Berenfeld A; Schandrin C; Lavarenne V
    Therapie; 1990; 45(5):411-3. PubMed ID: 1979694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Shock during combined administration of diltiazem and adrenergic beta receptor blockaders].
    Lan Cheong Wah LS; Robinet G; Guiavarc'h M; Garo B; Boles JM
    Rev Med Interne; 1992; 13(1):80. PubMed ID: 1357727
    [No Abstract]   [Full Text] [Related]  

  • 12. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
    Rogers R; Prpic R
    Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers: third-line antihypertensives.
    Prescrire Int; 2001 Aug; 10(54):121-3. PubMed ID: 11718186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of beta-adrenergic blocker and calcium channel antagonist toxicity.
    Kerns W
    Emerg Med Clin North Am; 2007 May; 25(2):309-31; abstract viii. PubMed ID: 17482022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction and anesthesia.
    Kim Y; Danchak M; Macnamara TE
    Clin Ther; 1987; 9(4):342-3. PubMed ID: 2886222
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
    Zeltser D; Justo D; Halkin A; Rosso R; Ish-Shalom M; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2004 Jul; 44(1):105-8. PubMed ID: 15234417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of blood pressure control.
    Jarvis SC
    Prof Nurse; 2004 Nov; 20(3):48. PubMed ID: 15552441
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
    Hilleman DE; Reyes AP; Mooss AN; Packard KA
    Curr Med Res Opin; 2003; 19(5):376-82. PubMed ID: 13678474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.